China Blood Products Market Increases Steadily, Driven By Increased Price And Government's Stricter Supervision
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - The sale of blood products in China reached $3.966 billion in 2008 with an annual growth rate 12.23 percent, according to consulting company Draco Healthcare. The growth will continue in the future, driven by increasing demand, limited supply and higher prices
You may also be interested in...
China Biologic Opens New Plasma Collection Station As China’s Blood Product Reforms Have Closed Doors For Many Competitors
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).